| INNATE PHARMA EO -,05 |
| Frankreich |
| Gesundheit |
| FR0010331421 / A0LCUJ |
| IDD (Frankfurt) |
| FRA:IDD, ETR:IDD, IDD:GR |
| - |
| https://www.innate-pharma.. |
|
Innate Pharma S.A. is a global, clinical-stage biotechnology company specializing in oncology-focused immunotherapies that harness the innate immune system to combat cancer. Founded in 1999 by pioneers in innate immunity, the company leverages expert..
>Volltext.. |
| 105.33 Mio. EUR |
| 93.6 Mio. EUR |
| 2.84 Mio. EUR |
| -59.87 Mio. EUR |
| -50.04 Mio. EUR |
| -0.56 EUR |
| 22.97 Mio. EUR |
| 28.58 Mio. EUR |
| -53.68 Mio. EUR |
| 0.94 |
| -77.92% |
| 0.59% |
| - |
| - |
| - |
| - |
| INNATE PHARMA |
| 05.04.26 |
|